Third People's Hospital of Jingdezhen City
Welcome,         Profile    Billing    Logout  
 21 Trials 
25 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
yang, li
NCT04376528: Mycophenolate Mofetil Versus Cyclosporin A in the Treatment of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome Due to Nonresponse to Standard Therapy

Recruiting
4
89
RoW
Cyclosporin A, Mycophenolate Mofetil
West China Hospital
Hepatitis, Autoimmune, Primary Biliary Cholangitis, Immunosuppression
12/21
12/21
NCT04617561: Ursodeoxycholic Acid Combined With Low Dose Glucocorticoid in the Treatment of PBC With AIH Features II

Recruiting
4
90
RoW
Ursodeoxycholic acid, UDCA;Ursofalk(250mg*25,Losan Pharma GmbH), Ursodeoxycholic acid+Low Dose Glucocorticoid(Methylprednisolone), Medrol(4mg*30,pfizer ltalia srl)
West China Hospital
Hepatitis, Autoimmune, Primary Biliary Cholangitis
11/22
11/22
NCT04618575: Ursodeoxycholic Acid Combined With Total Glucosides of Paeony in the Treatment of PBC With AIH Features 1

Recruiting
4
137
RoW
Ursodeoxycholic acid combined with total glucosides of paeony, Ursodeoxycholic acid only
West China Hospital
Hepatitis, Primary Biliary Cholangitis, Autoimmune
11/22
11/22
NCT04553003: Glucocorticosteroid Therapy on Drug-induced Liver Injury: a Prospective Non-randomized Concurrent Control Trial

Recruiting
4
80
RoW
Glucocorticoids+hepatoprotectant, prednisone, methylprednisolone, hepatoprotectant, Ademetionine1,4-Butanedisulfonate, Polyene Phosphatidyl choline
Li Yang
Drug-induced Liver Injury
04/25
04/25
NCT05463965: A Study to Evaluate the Efficacy and Safety of QM1114-DP for the Treatment of Moderate to Severe Glabellar Lines

Completed
3
605
RoW
QM1114-DP, OnabotulinumtoxinA, Placebo
Galderma R&D
Moderate to Severe Glabellar Lines
01/23
06/23
NCT06775860: ICP-332 in Subjects with Moderate to Severe Atopic Dermatitis

Recruiting
3
552
RoW
ICP-332 Tablets, ICP-332 Placebo Tablets
Beijing InnoCare Pharma Tech Co., Ltd.
Atopic Dermatitis
11/26
12/26
METIS, NCT02831959: Pivotal, Open-label, Randomized Study of Radiosurgery with or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases from Non-small Cell Lung Cancer (NSCLC).

Completed
3
298
Europe, Canada, US, RoW
NovoTTF-200M device, Best Standard of Care
NovoCure GmbH
Brain Metastases from Non-small Cell Lung Cancer (NSCLC)
11/24
11/24
CYCLONE 2, NCT03706365 / 2016-004276-21: A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate Cancer

Active, not recruiting
2/3
350
Europe, Japan, US, RoW
Abemaciclib, LY2835219, Abiraterone Acetate, Prednisone, Placebo
Eli Lilly and Company
Prostate Cancer
01/24
06/26
NCT06413654: A Clinical Study of B001 Injection in the Treatment of Neuromyelitis Optica Spectrum Disorders(NMOSD)

Recruiting
2/3
132
RoW
B001, Placebo
Shanghai Jiaolian Drug Research and Development Co., Ltd, Shanghai Pharmaceuticals Holding Co., Ltd
Neuromyelitis Optica Spectrum Disorders
10/27
02/29
NCT04492293: An Efficacy and Safety Study of ICP-192 in Subjects With Bladder Urothelial Cancer

Recruiting
2
115
RoW
ICP-192
Beijing InnoCare Pharma Tech Co., Ltd.
Bladder Urothelial Cancer
12/24
06/25
NCT02874586: Plasma Exchange Combination of Immunosuppressive Regimens for Auto-immune Hepatitis

Recruiting
N/A
20
RoW
Plasma exchange combination of immunosuppressive regimens
Xiaoli Fan
Hepatitis, Autoimmune
04/21
09/21
NCT02994537: Study of the Clinical Features of Autoimmune Hepatitis

Recruiting
N/A
500
RoW
Different biochemical results or pathogenesis.
Li Yang, West China Hospital
Hepatitis, Autoimmune
06/22
12/22
NCT02936596: Remission Induction of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome

Recruiting
N/A
53
RoW
Ursodeoxycholic acid combination of immunosuppressive agents, Ursodeoxycholic Acid
Xiaoli Fan
Hepatitis, Autoimmune, Cholangitis, Liver Cirrhosis, Biliary, Cholestasis
06/22
06/22
NCT04963010: Impact of SFV of Proximal Colon on ADR

Recruiting
N/A
910
RoW
second forward view
Zhu Xiaojia
Adenoma Detection Rate
06/22
06/22
NCT06597838: Development and Validation of a Real-time Prediction Model for Acute Kidney Injury in Hospitalized Patients

Recruiting
N/A
161876
RoW
Peking University First Hospital
Prediction Model
10/24
12/24
NCT06417736: Prospective Study for Endometrial Carcinoma and Hyperplasia in Childbearing-age Women

Recruiting
N/A
75
RoW
Megestrol Acetate 40 MG, membrane-inhibiting formula
Women's Hospital School Of Medicine Zhejiang University
Endometrial Cancer Stage I, Endometrial Hyperplasia
07/25
12/26
NCT05152446: Implementation of an Infusion Management Scheme to Improve Patient Outcome in Tertiary Children's Hospitals

Terminated
N/A
1000
RoW
Infusion management scheme
Children's Hospital of Fudan University, Xiamen Children's Hospital, Anhui Provincial Children's Hospital, Dalian women and children's medical group, First Affiliated Hospital of Guangxi Medical University, Qidong Women's and Children's Health, Chengdu Women's and Children's Central Hospital, Hunan Children's Hospital, Tongji Hospital
Children,Hospitalized, Infusion, Infections
11/24
11/24
NCT06076057: Vital Signs Monitoring of Emergency Responders in Different States

Recruiting
N/A
135
RoW
vital signs monitoring
Qilu Hospital of Shandong University
Heart Rate Monitoring
12/23
02/24
NCT06606522: A Clinical Diagnostic System for Intrinsic Acute Kidney Disease

Completed
N/A
1360
RoW
Clinical model, Urinary biomarkers
Peking University First Hospital, Affiliated Hospital of Hebei University, Beijing Miyun Hospital, Dongzhimen Hospital, Beijing University of Chinese Medicine, Taiyuan Central Hospital of Shanxi Medical University
Acute Kidney Disease
06/24
09/24
NCT06384300: Financial Incentives and Motivational Intervention to Improve Gastric Cancer Screening in China

Not yet recruiting
N/A
5000
NA
Financial Incentives, Motivational Intervention, Mixed Intervention
Peking University
Gastric Cancer
01/27
07/27
NCT03933891: Magnetic Resonance Technics for the Assessment of Liver Function Before and After TIPS

Recruiting
N/A
200
RoW
TIPS
West China Hospital
Liver Cirrhosis, Transjugular Intrahepatic Portosystemic Shunt (TIPS), Functional Magnetic Resonance Imaging
08/24
05/25
NCT05712304: Impact of SE of the Proximal Colon on the AMR

Recruiting
N/A
420
RoW
second examination of the proximal colon
Third People's Hospital of Jingdezhen City
Adenoma Miss Rate
12/24
12/24
NCT06123858: Non-alcoholic Steatohepatitis Registry Platform Study

Recruiting
N/A
2500
RoW
AstraZeneca
NASH With Fibrosis
12/26
12/26
Zhu, Xiaojia
NCT04963010: Impact of SFV of Proximal Colon on ADR

Recruiting
N/A
910
RoW
second forward view
Zhu Xiaojia
Adenoma Detection Rate
06/22
06/22
NCT05712304: Impact of SE of the Proximal Colon on the AMR

Recruiting
N/A
420
RoW
second examination of the proximal colon
Third People's Hospital of Jingdezhen City
Adenoma Miss Rate
12/24
12/24

Download Options